Researchers Create Accurate, Non-Invasive Test for Major Liver Diseases
This liquid biopsy test uses two circulating proteins to accurately test for non-alcoholic steato-hepatitis (NASH) and liver fibrosis.
Read MorePosted by Andy Lundin | Jul 14, 2022 | Diabetes & Metabolic Diseases |
This liquid biopsy test uses two circulating proteins to accurately test for non-alcoholic steato-hepatitis (NASH) and liver fibrosis.
Read MorePosted by Andy Lundin | Jul 5, 2022 | Diabetes & Metabolic Diseases |
In a study led by MedUni Vienna, a new method has now been used to determine alcohol consumption in fatty liver disease.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Diabetes & Metabolic Diseases |
A specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read MorePosted by Andy Lundin | Jun 3, 2022 | Diabetes & Metabolic Diseases |
Blood-based tests can be useful for initial diagnosis of liver disorders. Imaging methods are more accurate in assessing disorders severity.
Read MorePosted by Andy Lundin | Jun 1, 2022 | Disease States |
Death from alcohol-related liver disease can be prevented. In 2020 in the U.K. the alcohol-related mortality rate was its highest since 2001.
Read More